{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T08:29:10Z","timestamp":1674116950567},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.09.087","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T11:38:46Z","timestamp":1160566726000},"page":"1310-1315","source":"Crossref","is-referenced-by-count":3,"title":["Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia"],"prefix":"10.1016","volume":"25","author":[{"given":"J.L.","family":"Backhouse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.F.","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"MacIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.B.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.L.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.09.087_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","article-title":"Meningococcal polysaccharide-protein conjugate vaccines","volume":"5","author":"Snape","year":"2005","journal-title":"The Lancet Infects Dis"},{"key":"10.1016\/j.vaccine.2006.09.087_bib2","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JCM.29.11.2489-2493.1991","article-title":"Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada","volume":"29","author":"Ashton","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.09.087_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.273.5.383","article-title":"Serogroup C meningococcal outbreaks in the United States. An emerging threat","volume":"273","author":"Jackson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.09.087_bib4","first-page":"194","article-title":"Annual report of the Australian Meningococcal Surveillance Programme, 2003","volume":"28","author":"Anonymous","year":"2004","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2006.09.087_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S0950268899004471","article-title":"Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world","volume":"125","author":"Jelfs","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2006.09.087_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1139\/w05-085","article-title":"Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003","volume":"51","author":"Law","year":"2005","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.vaccine.2006.09.087_bib7","first-page":"6","article-title":"Australia's notifiable diseases status. 2002: Annual report of the National Notifiable Diseases Surveillance System","volume":"28","author":"Yohannes","year":"2004","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2006.09.087_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S0950268801006343","article-title":"Increase in meningococcal disease associated with the emergence of a novel ST-11 variant of serogroup C Neisseria meningitidis in Victoria, Australia, 1999\u20132000","volume":"128","author":"Tribe","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2006.09.087_bib9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.09.087_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2006.09.087_bib11","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.087_bib12","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.09.087_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2006.09.087_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","article-title":"Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom","volume":"186","author":"Borrow","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.09.087_bib15","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.09.087_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S095026889900285X","article-title":"Antimeningococcal herd immunity in the Czech Republic\u2014influence of an emerging clone, Neisseria meningitidis ET-15\/37","volume":"123","author":"Kriz","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2006.09.087_bib17","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1128\/JCM.41.12.5783-5786.2003","article-title":"First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy","volume":"41","author":"Stefanelli","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.09.087_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.micinf.2005.06.012","article-title":"Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37\/ST-11 clonal complex","volume":"8","author":"Lancellotti","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2006.09.087_bib19","series-title":"The Australian immunisation handbook","author":"Anonymous","year":"2003"},{"key":"10.1016\/j.vaccine.2006.09.087_bib20","first-page":"161","article-title":"Introduction of the National Meningococcal C Vaccination Program","volume":"27","author":"Cohen","year":"2003","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2006.09.087_bib21","first-page":"297","article-title":"Impact of the Australian Measles Control Campaign on immunity to measles and rubella","volume":"127","author":"Gilbert","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.09.087_bib22","series-title":"Population by age and sex, Australian states and territories","author":"AusStats","year":"1999"},{"key":"10.1016\/j.vaccine.2006.09.087_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CDLI.5.4.479-485.1998","article-title":"A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses","volume":"5","author":"Granoff","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.09.087_bib24","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0264-410X(02)00630-8","article-title":"Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era","volume":"21","author":"Trotter","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.087_bib25","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1016\/S0264-410X(02)00255-4","article-title":"A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia","volume":"20","author":"Kelly","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.087_bib26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2006.09.087_bib27","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.087_bib28","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.09.087_bib29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.09.087_bib30","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1128\/IAI.66.6.2453-2459.1998","article-title":"Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine","volume":"66","author":"Maslanka","year":"1998","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06010887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06010887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T14:32:05Z","timestamp":1587220325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06010887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06010887"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.09.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}